Overview
Revenue
$10 to $25 million (USD) per year
Headquarters
Greater Boston Area , East Coast , New England
We've manufactured over 8 million devices, three billion sensors, and developed the first FDA-cleared blood glucose meter/app for iPhone®. We've been featured by the New York Times and Fast Company, and work with some of the world's largest retailers (CVS, Kroger) and pharmaceutical companies (Sanofi, Perrigo) to change the way diabetes is treated. We have a vision for shaping the diabetes market through continuous innovations in biosensor technology and blood glucose monitoring. Our A-team of scientists, designers, and engineers will help to deliver solutions in connected health, high accuracy blood glucose testing, and intelligent meters that provide more than just a test result. AgaMatrix, Inc. manufactures biosensors and blood glucose monitors. The Company offers blood glucose monitoring systems, diabetes manager, and other devices. AgaMatrix serves customers worldwide. AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care.
